• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Influenza vaccine hesitancy in the elderly: Where do we stand?

tetano

Editor, Senior Moderator
Vaccine


. 2025 Oct 11:66:127831.
doi: 10.1016/j.vaccine.2025.127831. Online ahead of print. Influenza vaccine hesitancy in the elderly: Where do we stand?

Carla Pires[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Seasonal flu can cause severe illnesses and death, especially in risk groups, such as elderly.
Objectives: To identify and analyze studies related to influenza vaccine hesitancy and to identify the most reported factors/variables that explain vaccine hesitancy, regarding elderly.
Methods: A narrative review was carried out. Keywords were defined per each screened database: PubMed, SciELO and DOAJ.
Inclusion criteria: studies identifying potential explanatory factors of influenza vaccine hesitancy in older adults (last ten years).
Exclusion criteria: abstracts, letters to editors, commentaries, reviews, pilot and papers not written in Spanish, English, Portuguese and Italian. Variables related to vaccine hesitancy were identified and collected until saturation of data. These variables were codified according to 5C Model of Vaccine Hesitancy. Quality was checked with the Scale for the Assessment of Narrative Review Articles.
Results: 43 papers were selected. Overall, a set of sociodemographic variables and variables related to the 5C Model (e.g., confidence, complacency, constraints, risk calculation or collective responsibility) were identified as potentially relevant to explain vaccine hesitancy in elderly. The quality of the present narrative was classified as acceptable.
Conclusion: The present work makes a valuable contribution to the understanding influenza vaccine hesitancy in older populations, with the proposal of practical recommendations supported by literature. However, its narrative approach and single-author design limit the depth of analysis and the generalization of findings.

Keywords: 5C model; Elderly; Flu vaccine; Influenza; Narrative review; Vaccine hesitancy.

 
Back
Top Bottom